Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02684058
Title Phase II Pediatric Study With Dabrafenib in Combination With Trametinib in Patients With HGG
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

high grade glioma

Therapies

Dabrafenib + Trametinib

Age Groups: child
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL


No variant requirements are available.